drugset / Trial / NCT02755142
Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
RandomizedParallel-groupDouble-blind
Summary
This study is planned to detect a dose-efficacy relationship between the chosen dose levels of MC506/1 and the extent and quality of fluorescence in the tumour core in patients with newly diagnosed malignant glioma.
Timeline
- Start
- 2000-02
- Primary completion
- 2001-06
- Completion
- 2001-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aminolevulinic Acid | Diagnostic / imaging agent | 0.2 mg/kg | — |
| Comparator | Aminolevulinic Acid | Diagnostic / imaging agent | 2 mg/kg | — |
| Comparator | Aminolevulinic Acid | Diagnostic / imaging agent | 20 mg/kg | — |